Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination
Puo Nen Lim, Grant Wylie
Abstract
This is a case of symmetrical drug-related intertriginous and flexural exanthema-like eruption following ChAdOx1 nCoV-19 (AstraZeneca-Oxford) vaccination. Investigations, including repeated skin swabs, ruled out an infectious cause. He was subsequently treated with oral prednisolone, which led to a resolution of his symptoms.
Topics & Concepts
IntertriginousMedicineDrug eruptionDermatologyVaccinationPrednisoloneCoronavirus disease 2019 (COVID-19)VirologyDrugSurgeryPathologyInfectious disease (medical specialty)PharmacologyDiseaseDrug-Induced Adverse ReactionsImmunodeficiency and Autoimmune DisordersDermatological and COVID-19 studies